There's more to the story
The Rebif® (interferon beta-1a) story begins long before it was approved by the FDA in 2002 for the treatment of relapsing forms of MS. In fact, Rebif's well-established safety profile is backed by more than 20 years of clinical trial and patient experience. You may want to talk about that perspective when you and your healthcare professional are choosing a treatment for relapsing MS. Be sure to talk with your doctor about it, as well as the other important safety information on this page.
When you take Rebif, you can also count on the full support of MS LifeLines Nurses to help make sure you're injecting safely and correctly. And if you ever have questions about Rebif, Rebif side effects, or relapsing multiple sclerosis, remember that the help of MS LifeLines® is only a phone call away.
Possible side effects of Rebif include flu-like symptoms, skin reactions, depression and anxiety, liver problems, abdominal pain, blood problems, thyroid problems, and allergic reactions.
*Common adverse events have been consistent across clinical trials.
The safety and efficacy of treatment with Rebif beyond 2 years has not been established.
Pregnancy and Rebif
You should avoid becoming pregnant while taking Rebif until you have talked with your doctor.
If you become pregnant while taking Rebif, you should call your doctor right away. Rebif may cause you to lose your baby (miscarry) or may cause harm to your unborn child. You and your doctor will need to decide whether the potential benefit of taking Rebif is greater than the risks are to your unborn child.
Some things to remember
Rebif will not cure multiple sclerosis (MS) but it has been shown to decrease the number of flare-ups and slow the occurrence of some of the physical disability that is common in people with MS. Rebif can cause serious side effects, so before you start taking Rebif, you should talk with your healthcare provider about the possible benefits of Rebif and its possible side effects to decide if Rebif is right for you.